AUS
NZ
UK
CA
USA
IND
Cannabis
Is Numinus (TSX:NUMI) a psychedelic stock under 50 cents to buy?
July 19, 2022 02:01 AM EDT| By Kajal JainInvestors could look into this under-50-cents psychedelic stock listed on the Toronto Stock Exchange (TSX)
Tilray (TSX: TLRY): A cheap pot stock to buy right now?
July 18, 2022 03:31 AM EDT| By Kajal JainCanadian investors seeking significant growth exposure could explore pot stock Tilray (TSX: TLRY) to benefit from the possible federal decriminalization of marijuana in the United States.
Tilray (TLRY) and WEED: 2 TSX cannabis stocks to buy in July
July 01, 2022 06:52 AM EDT| By Kajal JainTSX pot stocks can see some significant gains in the long term if the industry sees federal decriminalization in the US, which has been in talks for a while now.
Is Canopy Growth (TSX: WEED) a cheap marijuana stock to buy?
May 30, 2022 11:12 AM EDT| By Kajal JainHighlights Stocks of Canopy Growth plummeted by nearly 14 per cent on Friday, May 27. The cannabis company reported a 25 per cent year-over-year (YoY) decline in Q4 2022. Canopy Growth, however, shortened its net loss in the latest quarter. .....
WEED, LOVE, TLRY, XLY & CRON: 5 Canada pot stocks to hold for 10 years
May 10, 2022 07:45 AM EDT| By Sundeep RadeshHighlights The S&P/TSX Cannabis Index has lost 38.4 per cent year-to-date (YTD) and nearly seven per cent Monday With both big US political parties on the green band wagon and a record 68 per cent of Americans approving of pot for recreatio...
WEED, TLRY, ACB, OGI & CRON: 5 TSX pot stocks SAFE Act may benefit
May 04, 2022 11:36 AM EDT| By Sundeep RadeshHighlights The S&P/TSX Cannabis Index is down 30.25 on a year-to-date (YTD) basis US senators from both sides of the political divide have lately been pushing for the SAFE Banking Act to pass All these stocks are on the rebound The ye.....
Stingray (RAY.B), CPG & MAL: 3 no-brainer TSX dividend stocks under $10
March 25, 2022 12:40 PM EDT| By Kajal JainHighlights Quality dividend stocks can help investors set off portfolio loss incurred due to the unfavourable market conditions, at least to some extent, if not wholly. Generally, investors with low-risk tolerance looking for an additiona.....
What is Cannabis 2.0 and can TLRY & WEED stocks boom this time?
March 25, 2022 12:31 PM EDT| By Kajal JainHighlights People are increasingly talking about Cannabis 2.0 as the US House of Representatives reportedly are expected to vote on the cannabis legalization bill next week. This move has spurred investors’ interest in some Canadian pot s.....
Tilray (TLRY) partners with HEXO: 2 TSX pot stocks to closely watch?
March 03, 2022 11:54 AM EST| By Kajal JainTilray Brands (TSX: TLRY) and Hexo Corp (TSX: HEXO) made headlines on Thursday, March 3, after the two cannabis giants announced a significant strategic alliance. In the wake of this new development, Tilray stock was dwindling by roughly four per .....
Royal Bank (TSX: RY) posts net profit of $4.1B in Q1. Time to buy?
February 24, 2022 09:18 AM EST| By Kajal JainRoyal Bank of Canada (TSX:RY) is gaining attention in the stock markets in the wake of its first-quarter results of fiscal 2022 being released on Thursday morning, February 24. RBC, one of the big six banks in Canada, is a dividend aristocrat and .....
Why is Tilray (TSX: TLRY) stock falling despite rapid expansion?
February 23, 2022 11:33 AM EST| By Kajal JainTilray Inc (TSX: TLRY) is creating a buzz on the stock markets following some recent developments in its cannabis business. Its stocks, however, plummeted was down by about four per cent at market close on Tuesday, February 22, despite this announ.....
Organigram (TSX: OGI) jumps 6% after sharp dip: A pot stock to watch?
February 16, 2022 09:47 AM EST| By Raza NaqviHighlights: Last month, Organigram released its first-quarter results and registered a 75 per cent year-over-year (YoY) growth in gross revenue. On February 15, many cannabis stocks jumped during the trading session, and OGI stock closed 6.3 pe.....
Canopy's (TSX:WEED) Q3 revenue declines. What's in store for investors?
February 09, 2022 10:12 AM EST| By Raza NaqviHighlights: In Q3 2022, the revenues were C$ 141 million, representing a decline of eight per cent year-over-year (YoY). Some analysts had reportedly expected Canopy to clock a revenue of C$ 137 million. Canopy Growth's gross margins declined .....
Tilray (TLRY) & Canopy (WEED): TSX pot stocks to take note of right now?
February 08, 2022 09:02 AM EST| By Kajal JainThe dream of cannabis legalization in the US had massively boosted Canadian pot stocks in 2020 around the time of the US presidential elections. Now, however, questions regarding its possibility seem to be hurting market sentiments. After high hop.....
2 TSX psychedelic stocks to trip on in February
January 31, 2022 09:10 AM EST| By Kajal JainSome Canadian pharmaceutical companies, like Numinus Wellness (TSX:NUMI) and Field Trip Health (TSX:FTRP), are said to be exploring legally approved psychedelic solutions to help people deal with different issues. A few recent studies have suggest.....
Canopy Growth (WEED) stock fell 72% in a year: Is it a cheap buy?
January 15, 2022 12:27 AM EST| By Kajal JainCanopy Growth Corporation (TSX: WEED) has been triggering some investor interest recently, despite a fall in its stock price. The pot maker is engaged in the business of cultivating, producing, and selling cannabis and hemp products for medical an.....
Numinus (TSX:NUMI): A psychedelic stock to explore amid 'shroom boom'?
January 13, 2022 09:47 AM EST| By Kajal JainStocks of Numinus Wellness Inc (TSX: NUMI) have been noting an uptick as the psychedelic-centered healthcare company nears the release of its Q1 FY2022 results this month. NUMI stock gained by over 13 per cent on Wednesday, January 12, recording a.....
What's next for Organigram (OGI) stock as it hits 'record' Q1 revenue?
January 11, 2022 09:19 AM EST| By Raza NaqviHighlights: In Q1 2022, Organigram narrowed its net loss to C$ 1.3 million from C$ 34.3 million in Q1 2021. Organigram posted net revenue of C$30.4 million in Q1 2022, a record feat for the company. Organigram expects to achieve positive adjus.....
Clearmind (CMND) returned 300% YTD! A psychedelic stock to trip on?
December 03, 2021 06:21 AM EST| By Raza NaqviHighlights Clearmind Medicine strengthened its balance sheet in 2021, and for the nine months ended July 31, the company had cash of C$ 6.6 million. As psychedelic stocks are becoming popular, investors have turned their attention to comp.....
The Green Organic (CSE:TGOD) rising on Q3 results. Buy call?
November 25, 2021 10:02 AM EST| By Raza NaqviHighlights The Green Organic is a global cannabis company and is known for its dedication towards innovation and sustainability. In Canada, Green Organic caters to the needs of the recreational cannabis market. The cannabis producer's gross re.....
